FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308616691> ?p ?o ?g. }

• W4308616691 endingPage "e602" @default.
• W4308616691 startingPage "e595" @default.
• W4308616691 abstract "Objectives The aim of this study was to investigate the use of procalcitonin (PCT) as a biomarker in differentiating bacterial infections from viral infections in cats. In addition, the relationship between PCT and mortality rate was also examined. Methods Forty-five cats were included in the study. The cats were categorised into two groups: bacterial (n = 20) and viral (n = 25) infection. Serum PCT level and PCT mRNA expression were analysed from blood samples collected before treatment. Results Serum PCT level and PCT mRNA expression of the cats with presumed bacterial infection were higher than those with viral infection ( P = 0.001 and P = 0.001, respectively). The receiver operating characteristic (ROC) curve analysis revealed an area under the ROC curve value of 0.888 for serum PCT and 0.850 for PCT mRNA expression. There was no statistically significant difference among respiratory, urinary and gastrointestinal tract infections regarding serum PCT level and PCT mRNA expression in the presumed bacterial infection group ( P = 0.741 and P = 0.141, respectively). In the presumed bacterial infection group, serum PCT level and PCT mRNA expression in the non-surviving cats were higher than those of the surviving cats ( P = 0.021 and P = 0.026, respectively). Conclusions and relevance Serum PCT level and PCT mRNA expression were considered efficient biomarkers in cats to distinguish a bacterial infection from a viral infection. Moreover, ROC curve analysis was highly accurate in the discriminative capacity of these two parameters. PCT level and PCT mRNA expression offer substantial assistance in an efficient therapeutic approach and in avoiding unnecessary antibiotic use in feline clinical practice, particularly in emergency patients and those with non-specific clinical signs, decreasing the mortality rate. However, it should be noted that these data are only research data. More detailed future studies are needed." @default.
• W4308616691 created "2022-11-13" @default.
• W4308616691 creator A5000483388 @default.
• W4308616691 creator A5010231390 @default.
• W4308616691 creator A5032609618 @default.
• W4308616691 creator A5035959997 @default.
• W4308616691 creator A5042636328 @default.
• W4308616691 creator A5046865445 @default.
• W4308616691 creator A5051343458 @default.
• W4308616691 creator A5068756378 @default.
• W4308616691 creator A5076409120 @default.
• W4308616691 date "2022-11-09" @default.
• W4308616691 modified "2023-10-03" @default.
• W4308616691 title "Use of serum procalcitonin (PCT) level and PCT mRNA expression as a potential clinical biomarker in cats with bacterial and viral infections" @default.
• W4308616691 cites W1488544337 @default.
• W4308616691 cites W1877300375 @default.
• W4308616691 cites W1970962136 @default.
• W4308616691 cites W1975437957 @default.
• W4308616691 cites W1980890002 @default.
• W4308616691 cites W1992612216 @default.
• W4308616691 cites W2050604996 @default.
• W4308616691 cites W2085544415 @default.
• W4308616691 cites W2093156013 @default.
• W4308616691 cites W2095504106 @default.
• W4308616691 cites W2101307430 @default.
• W4308616691 cites W2113324161 @default.
• W4308616691 cites W2115630110 @default.
• W4308616691 cites W2125056753 @default.
• W4308616691 cites W2128375804 @default.
• W4308616691 cites W2138904389 @default.
• W4308616691 cites W2143333241 @default.
• W4308616691 cites W2318431973 @default.
• W4308616691 cites W2320098398 @default.
• W4308616691 cites W2605520722 @default.
• W4308616691 cites W2610657413 @default.
• W4308616691 cites W2793113823 @default.
• W4308616691 cites W2796901557 @default.
• W4308616691 cites W2797187191 @default.
• W4308616691 cites W2949323336 @default.
• W4308616691 cites W2954251470 @default.
• W4308616691 cites W3002213867 @default.
• W4308616691 cites W3025116349 @default.
• W4308616691 cites W3092552251 @default.
• W4308616691 cites W4206209897 @default.
• W4308616691 cites W4250628849 @default.
• W4308616691 cites W4299689471 @default.
• W4308616691 cites W2151053406 @default.
• W4308616691 doi "https://doi.org/10.1177/1098612x221125570" @default.
• W4308616691 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36350675" @default.
• W4308616691 hasPublicationYear "2022" @default.
• W4308616691 type Work @default.
• W4308616691 citedByCount "1" @default.
• W4308616691 countsByYear W43086166912023 @default.
• W4308616691 crossrefType "journal-article" @default.
• W4308616691 hasAuthorship W4308616691A5000483388 @default.
• W4308616691 hasAuthorship W4308616691A5010231390 @default.
• W4308616691 hasAuthorship W4308616691A5032609618 @default.
• W4308616691 hasAuthorship W4308616691A5035959997 @default.
• W4308616691 hasAuthorship W4308616691A5042636328 @default.
• W4308616691 hasAuthorship W4308616691A5046865445 @default.
• W4308616691 hasAuthorship W4308616691A5051343458 @default.
• W4308616691 hasAuthorship W4308616691A5068756378 @default.
• W4308616691 hasAuthorship W4308616691A5076409120 @default.
• W4308616691 hasConcept C104317684 @default.
• W4308616691 hasConcept C105580179 @default.
• W4308616691 hasConcept C10936531 @default.
• W4308616691 hasConcept C126322002 @default.
• W4308616691 hasConcept C203014093 @default.
• W4308616691 hasConcept C2778384902 @default.
• W4308616691 hasConcept C2779904517 @default.
• W4308616691 hasConcept C2781197716 @default.
• W4308616691 hasConcept C55493867 @default.
• W4308616691 hasConcept C58471807 @default.
• W4308616691 hasConcept C63363279 @default.
• W4308616691 hasConcept C71924100 @default.
• W4308616691 hasConcept C76318530 @default.
• W4308616691 hasConcept C77411442 @default.
• W4308616691 hasConcept C86803240 @default.
• W4308616691 hasConcept C90924648 @default.
• W4308616691 hasConceptScore W4308616691C104317684 @default.
• W4308616691 hasConceptScore W4308616691C105580179 @default.
• W4308616691 hasConceptScore W4308616691C10936531 @default.
• W4308616691 hasConceptScore W4308616691C126322002 @default.
• W4308616691 hasConceptScore W4308616691C203014093 @default.
• W4308616691 hasConceptScore W4308616691C2778384902 @default.
• W4308616691 hasConceptScore W4308616691C2779904517 @default.
• W4308616691 hasConceptScore W4308616691C2781197716 @default.
• W4308616691 hasConceptScore W4308616691C55493867 @default.
• W4308616691 hasConceptScore W4308616691C58471807 @default.
• W4308616691 hasConceptScore W4308616691C63363279 @default.
• W4308616691 hasConceptScore W4308616691C71924100 @default.
• W4308616691 hasConceptScore W4308616691C76318530 @default.
• W4308616691 hasConceptScore W4308616691C77411442 @default.
• W4308616691 hasConceptScore W4308616691C86803240 @default.
• W4308616691 hasConceptScore W4308616691C90924648 @default.
• W4308616691 hasFunder F4320329283 @default.
• W4308616691 hasIssue "12" @default.
• W4308616691 hasLocation W43086166911 @default.

• next